ID   OECM-1
AC   CVCL_6782
SY   OECM1; OEC-M1; Meng-1
DR   BTO; BTO_0003964
DR   EFO; EFO_0022621
DR   cancercelllines; CVCL_6782
DR   Millipore; SCC180
DR   Wikidata; Q54931868
RX   PubMed=8083436;
RX   PubMed=9877329;
RX   PubMed=14720193;
RX   PubMed=15466821;
RX   PubMed=24825747;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 27 hours (PubMed=8083436).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (PubMed=14720193).
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24825747; obtained by personal communication of Yuan, Ta-Chun.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): Millipore=SCC180; PubMed=24825747
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 15
ST   FGA: 22,27 (Millipore=SCC180)
ST   FGA: 22,28 (PubMed=24825747)
ST   Penta D: 9,10
ST   Penta E: 20
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
RX   PubMed=8083436; DOI=10.1177/00220345940730080301;
RA   Yang C.-Y., Meng C.-L.;
RT   "Regulation of PG synthase by EGF and PDGF in human oral, breast,
RT   stomach, and fibrosarcoma cancer cell lines.";
RL   J. Dent. Res. 73:1407-1415(1994).
//
RX   PubMed=9877329; DOI=10.1016/S0003-9969(98)00078-8;
RA   Meng C.-L., Yang C.-Y., Shen K.-L., Wong P.Y.-K., Lee H.K.;
RT   "Inhibition of the synthesis of eicosanoid-like substances in a human
RT   oral cancer cell line by interferon-gamma and eicosapentaenoic
RT   acid.";
RL   Arch. Oral Biol. 43:979-986(1998).
//
RX   PubMed=14720193; DOI=10.1111/j.1600-0714.2004.00034.x;
RA   Lin S.-C., Liu C.-J., Chiu C.-P., Chang S.-M., Lu S.-Y., Chen Y.-J.;
RT   "Establishment of OC3 oral carcinoma cell line and identification of
RT   NF-kappa B activation responses to areca nut extract.";
RL   J. Oral Pathol. Med. 33:79-86(2004).
//
RX   PubMed=15466821; DOI=10.1093/jjco/hyh091;
RA   Huang G.-C., Liu S.-Y., Lin M.-H., Kuo Y.-Y., Liu Y.-C.;
RT   "The synergistic cytotoxicity of cisplatin and taxol in killing oral
RT   squamous cell carcinoma.";
RL   Jpn. J. Clin. Oncol. 34:499-504(2004).
//
RX   PubMed=24825747; DOI=10.1530/ERC-14-0102;
RA   Chang Y.-L., Hsu Y.-K., Wu T.-F., Huang C.-M., Liou L.-Y., Chiu Y.-W.,
RA   Hsiao Y.-H., Luo F.-J., Yuan T.-C.;
RT   "Regulation of estrogen receptor alpha function in oral squamous cell
RT   carcinoma cells by FAK signaling.";
RL   Endocr. Relat. Cancer 21:555-565(2014).
//